ReNeuron Group plc (RNUGF)

USD 0.0

(-97.18%)

Revenue Summary of ReNeuron Group plc

  • ReNeuron Group plc's latest annual revenue in 2023 was 530 Thousand GBP , up 31.51% from previous year.
  • ReNeuron Group plc's latest quarterly revenue in 2024 Q2 was 78.5 Thousand GBP , down 0.0% from previous quarter.
  • ReNeuron Group plc reported a annual revenue of 403 Thousand GBP in annual revenue 2022, up 56.81% from previous year.
  • ReNeuron Group plc reported a annual revenue of 257 Thousand GBP in annual revenue 2021, down -95.76% from previous year.
  • ReNeuron Group plc reported a quarterly revenue of 78.5 Thousand GBP for 2024 Q2, down 0.0% from previous quarter.
  • ReNeuron Group plc reported a quarterly revenue of 530 Thousand GBP for 2023 FY, up 31.51% from previous quarter.

Annual Revenue Chart of ReNeuron Group plc (2023 - 2003)

Historical Annual Revenue of ReNeuron Group plc (2023 - 2003)

Year Revenue Revenue Growth
2023 530 Thousand GBP 31.51%
2022 403 Thousand GBP 56.81%
2021 257 Thousand GBP -95.76%
2020 6.06 Million GBP 12277.55%
2019 49 Thousand GBP 13.95%
2018 43 Thousand GBP -6.52%
2017 46 Thousand GBP 58.62%
2016 29 Thousand GBP -3.33%
2015 30 Thousand GBP 36.36%
2014 22 Thousand GBP 29.41%
2013 17 Thousand GBP -57.5%
2012 40 Thousand GBP 37.93%
2011 29 Thousand GBP -6.45%
2010 31 Thousand GBP -66.67%
2009 93 Thousand GBP 244.44%
2008 27 Thousand GBP -44.9%
2007 49 Thousand GBP 444.44%
2006 9000.00 GBP 200.0%
2005 3000.00 GBP 200.0%
2004 1000.00 GBP -94.74%
2003 19 Thousand GBP 0.0%

Peer Revenue Comparison of ReNeuron Group plc

Name Revenue Revenue Difference
Capstone Therapeutics Corp. 48.35 Million USD 98.904%
Skye Bioscience, Inc. - USD -Infinity%
Santhera Pharmaceuticals Holding AG 122.95 Million USD 99.569%
Nascent Biotech, Inc. - USD -Infinity%
Qrons Inc. - USD -Infinity%
ProtoKinetix, Incorporated - USD -Infinity%
Adynxx, Inc. - USD -Infinity%
Arch Therapeutics, Inc. 75.72 Thousand USD -599.91%
BioStem Technologies, Inc. 16.68 Million USD 96.824%
Regen BioPharma, Inc. 236.56 Thousand USD -124.045%
CSL Limited 14.69 Billion USD 99.996%
Northwest Biotherapeutics, Inc. 1.93 Million USD 72.567%
Evofem Biosciences, Inc. 18.21 Million USD 97.091%
Rebus Holdings, Inc. - USD -Infinity%
Burzynski Research Institute, Inc. - USD -Infinity%
Neon Bloom, Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. 658.5 Thousand USD 19.514%
Eiger BioPharmaceuticals, Inc. 15.77 Million USD 96.64%
Nanobac Pharmaceuticals, Incorporated 17.62 Thousand USD -2907.775%
Institute of Biomedical Research Corp. - USD -Infinity%
SQZ Biotechnologies Company 21.47 Million USD 97.532%
Intellipharmaceutics International Inc. 65.72 Thousand USD -706.353%
Propanc Biopharma, Inc. - USD -Infinity%
Mesoblast Limited 5.9 Million USD 91.02%
Marizyme, Inc. 645.81 Thousand USD 17.933%
Genus plc 668.8 Million USD 99.921%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
Pharming Group N.V. 245.31 Million USD 99.784%
Therapeutic Solutions International, Inc. 98.99 Thousand USD -435.386%
CNBX Pharmaceuticals Inc. 410.16 Thousand USD -29.216%
Nymox Pharmaceutical Corporation - USD -Infinity%
ContraFect Corporation - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 76.76 Thousand USD -590.455%
IMV Inc. - USD -Infinity%
AXIM Biotechnologies, Inc. 39.51 Thousand USD -1241.161%
MultiCell Technologies, Inc. 49.32 USD -1074514.761%
ONE Bio Corp. 52.29 Million USD 98.987%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 49.72 Million USD 98.934%
Arno Therapeutics, Inc. - USD -Infinity%
EV Biologics, Inc. 48.9 Thousand USD -983.845%
Q BioMed Inc. 284.35 Thousand USD -86.389%
Emmaus Life Sciences, Inc. 29.59 Million USD 98.209%
Mosaic ImmunoEngineering Inc. - USD -Infinity%
Biomind Labs Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 145.09 Million USD 99.635%
Provectus Biopharmaceuticals, Inc. 557.71 Thousand USD 4.969%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Oncotelic Therapeutics, Inc. 70 Thousand USD -657.143%
GlobeStar Therapeutics Corporation - USD -Infinity%
THC Farmaceuticals, Inc. - USD -Infinity%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. - USD -Infinity%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Halberd Corporation 999.00 USD -52953.053%
Enzolytics Inc. 52.79 Thousand USD -903.864%
Agentix Corp. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Nuo Therapeutics, Inc. 608.52 Thousand USD 12.904%
MetaStat, Inc. - USD -Infinity%
argenx SE 1.22 Billion USD 99.957%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. 140.24 Thousand USD -277.918%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. 617.38 Thousand USD 14.154%
Zenith Capital Corp. - USD -Infinity%
Genscript Biotech Corporation 839.52 Million USD 99.937%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. - USD -Infinity%
WPD Pharmaceuticals Inc. - USD -Infinity%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Kadimastem Ltd - USD -Infinity%
Helix BioMedix, Inc. 997.72 Thousand USD 46.879%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
Regen BioPharma, Inc. 236.56 Thousand USD -124.045%
NovAccess Global Inc. - USD -Infinity%
Affymax, Inc. 1.36 Million USD 61.286%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
CytoDyn Inc. - USD -Infinity%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 473.73 Thousand USD -11.878%
SYBLEU INC 11.69 Thousand USD -4431.464%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. - USD -Infinity%
International Stem Cell Corporation 7.78 Million USD 93.196%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 13 Thousand USD -3976.923%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. - USD -Infinity%
Neutra Corp. 39.53 Thousand USD -1240.618%
Windtree Therapeutics, Inc. - USD -Infinity%
PureTech Health plc 3.33 Million USD 84.084%
Coeptis Therapeutics, Inc. - USD -Infinity%
IXICO plc 6.66 Million USD 92.048%
IntelGenx Technologies Corp. 1.03 Million USD 48.989%
Gelesis Holdings, Inc. 25.76 Million USD 97.943%
CSL Limited 14.8 Billion USD 99.996%
Cellectis S.A. 755 Thousand USD 29.801%